. Show Affiliations »
Abstract
Mesh: See more » Advisory CommitteesBlood Glucose/analysisBlood Glucose Self-MonitoringCalibrationDevice ApprovalDiabetes Mellitus, Type 1/bloodDiabetes Mellitus, Type 1/drug therapyDrug MonitoringHumansHyperglycemia/diagnosisHyperglycemia/prevention & controlHypoglycemia/chemically inducedHypoglycemia/diagnosisHypoglycemia/prevention & controlHypoglycemic Agents/administration & dosageHypoglycemic Agents/adverse effectsHypoglycemic Agents/therapeutic useInsulin/administration & dosageInsulin/adverse effectsInsulin/therapeutic useMonitoring, Ambulatory/adverse effectsMonitoring, Ambulatory/instrumentationPatient Education as TopicPractice Guidelines as TopicQuality of LifeUnited StatesUnited States Food and Drug Administration
Substances: See more » Blood GlucoseHypoglycemic AgentsInsulin
Year: 2016 PMID: 27472488 DOI: 10.1089/dia.2016.07252.mr
Source DB: PubMed Journal: Diabetes Technol Ther ISSN: 1520-9156 Impact factor: 6.118